
Jeffrey H. Murray
Examiner (ID: 2022, Phone: (571)272-9023 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1699, 1609 |
| Total Applications | 1761 |
| Issued Applications | 1272 |
| Pending Applications | 9 |
| Abandoned Applications | 485 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8186785
[patent_doc_number] => 20120115889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/335719
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 42782
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115889.pdf
[firstpage_image] =>[orig_patent_app_number] => 13335719
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/335719 | Inhibitors of Bruton's tyrosine kinase | Dec 21, 2011 | Issued |
Array
(
[id] => 8128469
[patent_doc_number] => 20120088782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'LPA RECEPTOR ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 13/330170
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63740
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088782.pdf
[firstpage_image] =>[orig_patent_app_number] => 13330170
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/330170 | LPA RECEPTOR ANTAGONIST | Dec 18, 2011 | Abandoned |
Array
(
[id] => 8173844
[patent_doc_number] => 20120108612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/328718
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 42766
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108612.pdf
[firstpage_image] =>[orig_patent_app_number] => 13328718
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/328718 | Inhibitors of Bruton's tyrosine kinase | Dec 15, 2011 | Issued |
Array
(
[id] => 9175235
[patent_doc_number] => 20130317220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'NOVEL PROCESSES FOR PREPARING TRIAZOLO[4, 5-d]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/996100
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22560
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996100
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996100 | NOVEL PROCESSES FOR PREPARING TRIAZOLO[4, 5-d]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | Dec 15, 2011 | Abandoned |
Array
(
[id] => 10870373
[patent_doc_number] => 08895572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Fused heterocyclic indane carboxamide CGRP receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 13/994905
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15553
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994905
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/994905 | Fused heterocyclic indane carboxamide CGRP receptor antagonists | Dec 15, 2011 | Issued |
Array
(
[id] => 9046893
[patent_doc_number] => 08541447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => '3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/326868
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28436
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13326868
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/326868 | 3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof | Dec 14, 2011 | Issued |
Array
(
[id] => 10039212
[patent_doc_number] => 09079910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => '5-(1,2,3-triazol-4-yl)-7H-pyrrolo[2,3-D]pyrimidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/978545
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13352
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978545
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978545 | 5-(1,2,3-triazol-4-yl)-7H-pyrrolo[2,3-D]pyrimidine derivatives | Dec 14, 2011 | Issued |
Array
(
[id] => 8140959
[patent_doc_number] => 20120095026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/312606
[patent_app_country] => US
[patent_app_date] => 2011-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 42792
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095026.pdf
[firstpage_image] =>[orig_patent_app_number] => 13312606
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/312606 | Inhibitors of Bruton's tyrosine kinase | Dec 5, 2011 | Issued |
Array
(
[id] => 8056651
[patent_doc_number] => 20120077979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => '6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/308694
[patent_app_country] => US
[patent_app_date] => 2011-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 137239
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077979.pdf
[firstpage_image] =>[orig_patent_app_number] => 13308694
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/308694 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | Nov 30, 2011 | Issued |
Array
(
[id] => 8043533
[patent_doc_number] => 20120071490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'P70 S6 KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/307560
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27533
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071490.pdf
[firstpage_image] =>[orig_patent_app_number] => 13307560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/307560 | P70 S6 KINASE INHIBITORS | Nov 29, 2011 | Abandoned |
Array
(
[id] => 8896762
[patent_doc_number] => 08476283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => '[6,5]—bicyclic GPR119 G protein-coupled receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 13/307698
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28844
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13307698
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/307698 | [6,5]—bicyclic GPR119 G protein-coupled receptor agonists | Nov 29, 2011 | Issued |
Array
(
[id] => 10580875
[patent_doc_number] => 09302989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'NAMPT and rock inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/294303
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 501764
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294303
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294303 | NAMPT and rock inhibitors | Nov 10, 2011 | Issued |
Array
(
[id] => 8199469
[patent_doc_number] => 20120122900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/293177
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23806
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122900.pdf
[firstpage_image] =>[orig_patent_app_number] => 13293177
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/293177 | Piperidinone carboxamide azaindane CGRP receptor antagonists | Nov 9, 2011 | Issued |
Array
(
[id] => 9016394
[patent_doc_number] => 20130231358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'PIPERIDINONE CARBOXAMIDE INDANE CGRP RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/884632
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22735
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884632
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884632 | Piperidinone carboxamide indane CGRP receptor antagonists | Nov 9, 2011 | Issued |
Array
(
[id] => 9778024
[patent_doc_number] => 08853228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-07
[patent_title] => 'Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase'
[patent_app_type] => utility
[patent_app_number] => 13/290741
[patent_app_country] => US
[patent_app_date] => 2011-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 36175
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13290741
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/290741 | Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase | Nov 6, 2011 | Issued |
Array
(
[id] => 8278503
[patent_doc_number] => 20120172379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => '4 SUBSTITUTED PYRAZOLOPYRIMIDINES'
[patent_app_type] => utility
[patent_app_number] => 13/289300
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22074
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13289300
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/289300 | 4 SUBSTITUTED PYRAZOLOPYRIMIDINES | Nov 3, 2011 | Abandoned |
Array
(
[id] => 8199444
[patent_doc_number] => 20120122888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Potassium Channel Modulators'
[patent_app_type] => utility
[patent_app_number] => 13/287635
[patent_app_country] => US
[patent_app_date] => 2011-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56136
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122888.pdf
[firstpage_image] =>[orig_patent_app_number] => 13287635
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/287635 | Potassium channel modulators | Nov 1, 2011 | Issued |
Array
(
[id] => 8977409
[patent_doc_number] => 20130210839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'FUSED AMINODIHYDROPYRIMIDINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/881112
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23982
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881112 | Fused aminodihydropyrimidine derivative | Oct 26, 2011 | Issued |
Array
(
[id] => 7778562
[patent_doc_number] => 20120041003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME'
[patent_app_type] => utility
[patent_app_number] => 13/277909
[patent_app_country] => US
[patent_app_date] => 2011-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31096
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041003.pdf
[firstpage_image] =>[orig_patent_app_number] => 13277909
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/277909 | Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme | Oct 19, 2011 | Issued |
Array
(
[id] => 10831413
[patent_doc_number] => 08859582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/275752
[patent_app_country] => US
[patent_app_date] => 2011-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34975
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13275752
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/275752 | Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors | Oct 17, 2011 | Issued |